Bank of America
ANAC

Bank of America’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bank of America’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-48,800
Closed -$2.61M – 7808
2016
Q1 		$2.61M Buy
48,800
+200
+0.4% +$14.8K ﹤0.01% 3344
2015
Q4 		$5.49M Buy
+48,600
New +$5.35M ﹤0.01% 2851

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Bank of America's ANAC Position: Q2 2016 in Review

Bank of America sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 172,011 shares — an estimated $9.19M sold.

Bank of America first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $17M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Bank of America reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Bank of America sold 172,011 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $9.19M.
  • Bank of America first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Bank of America's ANACOR PHARMACEUTICALS INC COM position peaked at $17M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Bank of America's 13F filing for Q2 2016, filed 15 Aug 2016.